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Abstract
Background: Lumbar spinal stenosis is the most frequent reason for spinal surgery in elderly people. For patients
with moderate or severe symptoms different conservative and surgical treatment modalities are recommended, but
knowledge about the effectiveness, in particular of the conservative treatments, is scarce. There is some evidence
that surgery improves outcome in about two thirds of the patients. The aims of this study are to derive and
validate a prognostic prediction aid to estimate the probability of clinically relevant improvement after surgery and
to gain more knowledge about the future course of patients treated by conservative treatment modalities.
Methods/Design: This is a prospective, multi-centre cohort study within four hospitals of Zurich, Switzerland. We
will enroll patients with neurogenic claudication and lumbar spinal stenosis verified by Computer Tomography or
Magnetic Resonance Imaging. Participating in the study will have no influence on treatment modality. Clinical data,
including relevant prognostic data, will be collected at baseline and the Swiss Spinal Stenosis Questionnaire will be
used to quantify severity of symptoms, physical function characteristics, and patient’s satisfaction after treatment
(primary outcome). Data on outcome will be collected 6 weeks, and 6, 12, 24 and 36 months after inclusion in the
study. Applying multivariable statistical methods, a prediction rule to estimate the course after surgery will be
derived.
Discussion: The ultimate goal of the study is to facilitate optimal, knowledge based and individualized treatment
recommendations for patients with symptomatic lumbar spinal stenosis.
Background
Pain radiating to lower extremities is a frequent com-
plaint, especially in elderly people, and lumbar spinal
stenosis is one of the underlying conditions. Lumbar
spinal stenosis is defined as “buttock or lower extremity
pain, which may occur with or without low back pain,
associated with diminished space available for the neural
and vascular elements in the lumbar spine”[1]. Narrow-
ing can be localized at three different anatomic struc-
tures, the central canal, the lateral recess, or the neural
foramina.
Patients complain of neurogenic claudication (pain in
the buttocks and lower extremities with or without low
back pain provoked by walking or extended standing
a n dr e l i e v e db yr e s ta n db e n d i n gf o r w a r d )t h a ti s
compatible with a narrowing of the lumbar spinal canal.
In some patients Computer Tomography (CT) or
Magnetic Resonance Imaging (MRI) can verify a stenosis
in the lumbar spinal region, in others not. Vice versa a
remarkable proportion of asymptomatic persons
older 60 years show substantial narrowing of the spinal
canal [2].
T h ei n c i d e n c ea n dp r e v a l e n c eo fs y m p t o m a t i cl u m b a r
stenosis are unknown. It is estimated from data in the
USA that every year 90 out of 100.000 persons older
than 60 years undergo lumbar surgery and lumbar
spinal stenosis is the most frequent indication for this
procedure [3,4]. In the Canton of Zurich with 1.3 Mio
(2008) inhabitants we estimate that more than 300
operations on patients with lumbar spinal stenosis are
performed every year.
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The natural course of spinal stenosis can vary, but is in
most patients a relatively stable disorder, with severe
disability and neurological deficits developing over time
and not rapidly. In the SPORT trial it was reported that
in most patients treated conservatively, symptoms did
not worsen over four years [5]. A further trial focusing
on development of pain over a five year period showed
that in 70% of patients pain reached a plateau, in 15%
pain increased over time and in 15% pain disappeared
spontaneously [6,7].
For patients with moderate or severe symptoms differ-
ent conservative and surgical treatment modalities are
recommended, but knowledge about the effectiveness of
these measures is scarce. Most of the studies evaluating
non-operative treatments are of low quality and there is
a lack of knowledge about the appropriate treatment of
these patients [1,8]. There is little evidence that pharma-
cological treatment, including non-steroidal analgesics,
calcitonin, methylcobalamin or intravenous lipoprosta-
glandin E, provides long-term benefit in patients with
lumbar spinal stenosis [1]. A systematic review of the
literature yielded insufficient evidence to draw conclu-
sions regarding the effectiveness of physical therapy for
lumbar spinal stenosis. In certain subgroups of patients
physical therapy and exercise may be beneficial in con-
trolling symptoms of neurogenic claudication in lumbar
spinal stenosis, but the evidence that spinal manipula-
tion offers benefit in the treatment is insufficient [1,8].
Epidural injections may have potential benefit and
may be tried before surgery, but results about efficiency
are mixed [9-13]. Some data suggest that epidural injec-
tion of corticosteroids relieves leg pain for a limited
time but has no effect on the functional status or the
need for surgery after one year [14]. The authors of a
systematic review came to the conclusion that evidence
is insufficient to recommend epidural injections in
patients with spinal stenosis [15].
T h e r ei ss o m ee v i d e n c ef r o mr a n d o m i z e dt r i a l s
[5,16,17] and observational studies [18-22] that surgery
improves symptoms in patients with spinal stenosis. The
therapeutic effectiveness of conservative measures or
surgery, as mentioned in the guidelines of the North
American Spine Society, should be evaluated by further
randomised controlled trials [1]. Such trials, however, as
demonstrated in the study by Weinstein [16], are diffi-
cult to execute in patients with spinal stenosis. In the
aforementioned study, patients with spinal stenosis were
randomly allocated to either surgery or conservative
treatment. Two years after randomization, only 67% of
patients in the surgical group actually received surgery
and 43% of those who were assigned to conservative
treatment had also undergone surgery. Physicians and/
or patients seem to have strong preferences for surgery
or conservative therapy impeding the accomplishment
of randomised trials [23].
The long term success rates of surgery vary between
45% and 72%, depending on the measured clinical out-
come assessed (pain, walking capacity, neurologic symp-
toms, working ability) [24]. The outcome of surgery
depends on a number of different factors. Indicators of
postoperative outcome have been evaluated in different
populations and the results have been summarized in a
systematic review [25,26]. A lower self rated preopera-
tive health-status, comorbidity, depression and limited,
preoperative walking ability are strong predictors of an
unfavorable clinical outcome.
Methods/Design
Study design
This multi-centre prospective cohort study includes
patients with neurogenic claudication and radiological
findings of lumbar spinal stenosis.
Objectives
1. To develop a prognostic probability function (pre-
diction rule) in order to predict the further course
(one, two and three years after diagnosis) in patients
with lumbar spinal stenosis undergoing surgery.
2. To develop (a) prognostic probability function(s)
(prediction rules) in order to predict the further
course (one, two and three years after diagnosis) in
patients with lumbar spinal stenosis treated, at least
initially, by conservative measures.
Eligibility Criteria and identifying patients
Patients will be recruited in four hospitals in Zurich
(University Hospital, University Clinic Balgrist,
Schulthess Clinic and City Hospital Triemli). To be eli-
gible for the study the participants must: 1) be aged 50
years or more; 2) have uni- or bilateral neurogenic clau-
dication (defined by pain in the buttocks and/or lower
extremities provoked by walking or extended standing
and relieved by rest and/or bending forward; 3) have a
verified diagnosis of spinal stenosis by Computer tomo-
graphy or Magnetic Resonance Imaging (criteria are
s h o w ni nt a b l e1 ) [ 2 7 ] ;4 )h a v ea ne x p e c t e dl i f ee x p e c -
tancy of more than one year; 5) be able to give informed
consent; 6) be available for follow-up and able to com-
plete questionnaires in German language. Exclusion cri-
teria are: 1) cauda equina syndrome requiring urgent
surgery; 2) current fracture, infection or significant
deformity (> 15° lumbar scoliosis); 3) current enrolment
in another spine related treatment study; 4) clinically
relevant peripheral arterial disease (confirmed by vascu-
lar specialist in patients without palpable pulses in the
lower limb).
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Sample size is calculated for objective one, the develop-
ment of a prognostic function for patients undergoing
spine surgery, one year after surgery. Outcome after sur-
gery will be quantified by the Swiss Spinal Stenosis
Questionnaire (SSM)[28] and results will be dichoto-
mized. An improvement of more than 0.5 points on the
symptom severity scale and physical function scale in
the SSM will be categorized as improved. According to
the original publication [28] 0.5 points represents a
clinically relevant improvement for the patients (Mini-
mal Clinical Important Difference). We estimate that
60% of all patients with verified diagnosis will undergo
surgery and two thirds of these (between 60% and 70%)
of patients will show an improvement of more than 0.5
points in both scales (symptom severity and physical
function) one year after surgery. To estimate the effect
of ten prognostic variables we need roughly 100 patients
without improvement, as defined above, after surgery.
This leads us to include 350 patients in the study who
undergo surgery.
Procedure
Patients will be recruited during consultations in the
Rheumatology and Spine surgery units of all participat-
ing hospitals. Patients who fulfil the inclusion criteria
will be informed about the goals and execution of the
study and written informed consent will be obtained.
Baseline and follow-up data will be collected by physi-
cians assisted by study nurses. An overview of the study
flow is given in Figure 1. In a preliminary phase of the
study we will validate the German version of the Swiss
Spinal Stenosis Questionnaire. This questionnaire is
recommended for outcome measurement by the North
American Spine Society.
After quality control all data will be stored in a central
data base. All the recorded data and information con-
tained within the study will remain strictly confidential.
All the personal data will be made anonymous and
assigned a code. The decoding will be stored at the Hor-
ten Centre and will be accessible only to the principle
investigator. We will ensure that anonymization is main-
tained throughout any collaboration with other investi-
gators. The data management will comply with the
federal law of data protection of Switzerland.
Treatment
The choice of treatment is not influenced by participa-
tion in the study and depends only on the clinical situa-
tion, physician’s advice, and patients decision.
Treatment options are watchful waiting, conservative
treatment with physical therapy and/or drugs, epidural
injections of analgesics and/or steroids and surgery.
Detailed information about treatment(s) will be recorded
using pre-specified questionnaires at each follow up
visit. The questionnaire will comprise specific questions
about: mode, duration and frequency of physical ther-
apy; duration and dosage of drug treatments; site of epi-
dural injection, with or without imaging, dosage of
injected drugs; surgeon, precise and detailed description
of surgical technique and procedure, intra- and post-
operative complications, duration of surgical procedure
Table 1 Radiological criteria for lumbar spinal stenosis (L1 to L5)
!
Location of stenosis Radiological criteria (L1 to L5)
Central canal stenosis Antero-posterior diameter of spinal canal ≤12 mm[31], or cross sectional area of dural tube ≤100 mm
2 [30]
Lateral recess stenosis Lateral recess height ≤ 3 mm, or lateral recess depth ≤ 5 mm [32,34,35]
Foraminal stenosis Foraminal diameter ≤ 5 mm [36]
1L lumbar vertebra.
Figure 1 Study flow.
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geons who have performed more than one hundred
operations on the lumbar spine within the last two years
will be included in the study.
Data to be collected
At baseline information about socio-demographic char-
acteristics, symptoms, clinical examination, consumption
of analgesics and other treatments for lumbar spinal ste-
nosis within the last 6 months will be collected. Radiolo-
gical findings (CT, MRI) at different measurement
points between lumbar vertebra 1 to lumbar vertebra 5
(central stenosis: antero-posterior diameter of spinal
canal, cross sectional area of dural tube, interpedicular
distance[29-31]; lateral stenosis: height and depth of the
lateral recess [32-35]; foraminal stenosis: foraminal dia-
meter will be quantified [36].
Comorbidities will be assessed with the validated
Cumulative illness rating scale (CIRS) [37] which rates
the presence and severity of comorbid diseases in 13
organ systems from 0 to 4, and sums organ-specific
scores across systems to yield a summary score. Depres-
sion, a prognostic indicator, will be quantified with the
Hospital Anxiety and Depression Score (HADS). The
questionnaire consists of 14 questions, seven for anxiety
and seven for depression [38].
Information about treatment will be collected at base-
line for six months preceding enrolment in the study and
at each follow-up visit for the period between the visits.
Outcome measures (baseline and follow up)
Primary and secondary outcome data will be collected at
baseline and at six weeks and six months after the time
of treatment onset (surgery for the surgery group and
time of enrolment for the nonsurgical group). Long-
term outcome data will be gathered after one year and
then annually up to three years.
Primary Outcome
The Swiss Spinal Stenosis Questionnaire (SSM)[28] has
been recommended by the North American Spine
Society (NASS) [1] as the “gold standard” to quantify
outcome in patients with spinal stenosis, will be used to
quantify outcome. The SSM consists of three different
subscales; severity of symptoms (possible range of the
score is 1 to 5), physical function characteristics (possi-
ble range of scores is 1 to 4) and patient’s satisfaction
after treatment (the range of the scale is 1 to 4). In the
present study, both the severity of symptoms and the
physical function scales will represent the primary out-
come, whereby a minimum of 0.5-point change in each
will be required for the treatment to be considered a
success. The SSM has been used as the primary
outcome in different studies on lumbar spinal stenosis
[39-43] and a German version is available.
Secondary Outcomes
1. Bodily pain and physical function with 36-item
Short-Form General Health Survey (SF-36) [44-46].
SF-36 scores range from 0 to 100, with higher scores
indicating less severe symptoms.
2. Modified Oswestry Disability Index [46]. The
Oswestry Disability Index ranges from 0 to 100, with
lower scores indicating less severe symptoms.
Ethics
The study will be conducted in accordance with the
principles outlined by the 18
th World Medical Assembly,
the Declaration of Helsinki (World Medical Association
International Code of Medical Ethics (WMA) General
Assembly, Pilanesberg, South Africa, October 2006) and
all applicable amendments detailed by the World Medi-
cal Assemblies, the ICH (The International Conference
on Harmonisation of Technical Requirements for Regis-
tration of Pharmaceuticals for Human Use) guidelines
for Good Clinical Practice (GCP), and the Medical
Research Involving Human Subjects Act of the Swiss
Academy of Medical Sciences. This cohort study will be
conducted in compliance with all international laws and
regulations as well as any applicable guidelines.
Statistical analysis
Epidemiologic data and patients’ descriptive data avail-
able on continuous scales will be presented with med-
ians, interquartile ranges or means and standard
deviations as appropriate. Categorical data will be pre-
sented as rates and percentages. Associations of the con-
tinuous independent variables with the outcome
variables will be reported using simple logistic regres-
sions. Results from univariate analysis will guide multi-
variable modeling.
Assessment of associations will be performed using
multi-variable models including potential confounders
along with the independent variables of interest. Prog-
nostic scores will be built using either logistic regression
analysis or Cox proportional hazard models. Models will
be validated in subsamples by cross validation. Calibra-
tion and discrimination of the cross-validated prognostic
instruments will be assessed using the Brier Score.
Discussion
This protocol describes the rational, methodology and
design of a prospective, multi-center cohort study within
hospitals in Zurich including patients with symptomatic
lumbar spinal stenosis.
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indicators predicting the future course of patients with
lumbar spinal stenosis with and without surgical ther-
apy. These results will support physicians in informing
patients, some of them suffering from more than one ill-
ness, about the expected course of the illness and help
patients and physicians in deciding which therapy to
choose.
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